| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Director | President &CEO
3 companies
Traber Peter G is a Chief Medical Officer at Cartesian Therapeutics, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 6 buys and 9 sells.
Estimated insider holdings value: $4.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 25, 2023 | RNAC Cartesian Therapeutics, Inc. | Chief Medical Officer | Sell | 705 | $1.06 | $747.30 | -0.2% | -30.9% | -50.2% | |
| Jan 5, 2023 | RNAC Cartesian Therapeutics, Inc. | Chief Medical Officer | Sell | 11,644 | $1.13 | $13,185.32 | -0.6% | +12.1% | -46.3% | |
| Jan 5, 2022 | RNAC Cartesian Therapeutics, Inc. | Chief Medical Officer | Sell | 3,226 | $3.09 | $9,955.11 | -1.3% | -56.3% | -61.6% | |
| Dec 10, 2021 | RNAC Cartesian Therapeutics, Inc. | Chief Medical Officer | Sell | 4,083 | $2.99 | $12,195.51 | -2.4% | -41.9% | -58.8% | |
| Oct 13, 2021 | RNAC Cartesian Therapeutics, Inc. | Chief Medical Officer | Sell | 3,636 | $4.39 | $15,962.04 | -2.3% | -35.4% | -63.4% | |
| May 26, 2021 | RNAC Cartesian Therapeutics, Inc. | Chief Medical Officer | Buy | 20,000 | $3.99 | $79,850.00 | +17.3% | -1.5% | -82.9% | |
| May 25, 2021 | RNAC Cartesian Therapeutics, Inc. | Chief Medical Officer | Buy | 17,500 | $3.37 | $58,897.50 | +8.4% | +14.8% | -80.2% | |
| Mar 18, 2021 | RNAC Cartesian Therapeutics, Inc. | Chief Medical Officer | Buy | 20,000 | $4.51 | $90,295.00 | +12.0% | +11.4% | -63.6% | |
| Dec 14, 2020 | RNAC Cartesian Therapeutics, Inc. | Chief Medical Officer | Buy | 40,000 | $3.24 | $129,424.00 | New | - | - | |
| Jun 13, 2018 | GALT Galectin Therapeutics Inc | President &CEO | Sale+OE | 100,000 | $7.51 | $751,000.00 | -48.2% | - | - |